Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Pathologic Considerations and Standardization in Mesothelioma Clinical Trials.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pathologic Considerations and Standardization in Mesothelioma Clinical Trials.
Pathologic Considerations and Standardization in Mesothelioma Clinical Trials. J Thorac Oncol. 2019 10; 14(10):1704-1717.
View in:
PubMed
subject areas
Biological Specimen Banks
Biomarkers, Tumor
Clinical Trials as Topic
Diagnosis, Differential
Humans
Mesothelioma
Pleural Neoplasms
authors with profiles
Ravi Salgia